Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 224.00
+0.50 (0.22%)
Apr 24, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 58.87 billion as of April 24, 2026. Its market cap has decreased by -11.61% in one year.
Market Cap
58.87B
Enterprise Value
98.61B
Revenue
20.51B
Ranking
n/a
PE Ratio
12.42
Stock Price
224.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 58.87B, an increase of 540.76%. That is a compound annual growth rate of 17.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 58.87B | -20.90% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 240.14B |
| Bora Pharmaceuticals | 53.21B |
| Center Laboratories | 30.23B |
| TTY Biopharm Company | 18.18B |
| Grape King Bio | 17.41B |
| ScinoPharm Taiwan | 16.92B |
| Synmosa Biopharma | 15.89B |
| YungShin Global Holding | 14.70B |